MARKET

PHAT

PHAT

Phathom Pharmaceuticals, Inc.
NASDAQ
14.70
+0.03
+0.20%
After Hours: 14.69 -0.01 -0.07% 19:39 12/04 EST
OPEN
14.67
PREV CLOSE
14.67
HIGH
14.91
LOW
14.27
VOLUME
530.07K
TURNOVER
--
52 WEEK HIGH
16.27
52 WEEK LOW
2.210
MARKET CAP
1.05B
P/E (TTM)
-3.8557
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHAT last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at PHAT last week (1117-1121)?
Weekly Report · 11/24 09:51
Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth
Seeking Alpha · 11/21 21:03
Weekly Report: what happened at PHAT last week (1110-1114)?
Weekly Report · 11/17 09:51
Could Expanding VOQUEZNA’s Pipeline Mark a New Strategic Phase for Phathom Pharmaceuticals (PHAT)?
Simply Wall St · 11/15 08:27
Phathom Pharmaceuticals (PHAT): Assessing Valuation After First Patient Dosed in VOQUEZNA EoE Phase 2 Trial
Simply Wall St · 11/13 02:21
Surprising Analyst 12-Month Target For ITOT
NASDAQ · 11/12 11:59
Weekly Report: what happened at PHAT last week (1103-1107)?
Weekly Report · 11/10 09:49
More
About PHAT
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s product candidates include VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker, or potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.

Webull offers Phathom Pharmaceuticals Inc stock information, including NASDAQ: PHAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHAT stock methods without spending real money on the virtual paper trading platform.